Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» CLL
CLL
TG Therapeutics completes FDA filing for Roche challenger in CLL
TG Therapeutics completes FDA filing for Roche challenger in CLL
Pharmaforum
TG Therapeutics
FDA
antibodies
CLL
ublituximab-umbralisib
Flag link:
AZ says Calquence is a safer drug than Imbruvica
AZ says Calquence is a safer drug than Imbruvica
Pharmaforum
AstraZeneca
Calquence
Imbruvica
JNJ
AbbVie
CLL
Flag link:
TG Therapeutics set for upsized IPO to develop cancer combination drug
TG Therapeutics set for upsized IPO to develop cancer combination drug
Pharmaforum
TG Therapeutics
ASH2020
IPOs
CLL
Flag link:
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
AstraZeneca
BeiGene
JNJ
AbbVie
Calquence
Brukinsa
Imbruvica
CLL
ASH2020
Flag link:
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Pharmaceutical Business Review
JNJ
Janssen
Europe
Imbruvica
rituximab
CLL
Flag link:
AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise
AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise
Endpoints
AbbVie
JNJ
Imbruvica
FDA
CLL
SLL
Flag link:
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Pharmaceutical Business Review
Janssen
JNJ
EMA
Imbruvica
CLL
Flag link:
Leukemia rivals try to stay ahead as Merck, Lilly chase
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
Flag link:
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Eli Lilly
Loxo Oncology
ASH2019
CLL
Flag link:
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
Flag link:
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
AbbVie
Roche
CLL
ASH2019
Venclexta
Flag link:
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
AstraZeneca
FDA
CLL
SLL
Calquence
Flag link:
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
Fierce Pharma
AstraZeneca
Calquence
Imbruvica
CLL
JNJ
AbbVie
Flag link:
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
Pharmaceutical Business Review
AbbVie
Imbruvica
rituximab
CLL
SLL
Flag link:
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
AstraZeneca
clinical trials
Imfinzi
extensive-stage small cell lung cancer
Calquence
CLL
Flag link:
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
AstraZeneca
Calquence
CLL
Imbruvica
Flag link:
AstraZeneca ends another Calquence trial early
AstraZeneca ends another Calquence trial early
Pharmaforum
AstraZeneca
CLL
Calquence
clinical trials
Flag link:
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
Fierce Pharma
AbbVie
Roche
Venclexta
CLL
small lymphocytic leukemia
Flag link:
ASH successes set to lift Imbruvica in CLL
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
AbbVie
Imbruvica
CLL
JNJ
ASH 2018
Flag link:
ASH18: CAR-T shows up in early CLL test
ASH18: CAR-T shows up in early CLL test
Biopharma Dive
Celgene
CAR-T
CLL
ASH2018
JCAR017
Flag link:
Pages
1
2
3
4
next ›
last »